A finite course of peginterferon alfa-2a results in inactive chronic hepatitis b and hbsag clearance 5 years post-treatment in patients with hbeag-negative disease: Baseline characteristics and predictive factors of long-term response

Marcellin, PatrickPiratvisuth, TeerhaBrunetto, MauriziaBonino, FerruccioFarci, PatriziaYurdaydın, CihanKapprell, Hans PeterMessinger, DiethelmBatrla, Richard2022-06-092022-06-092009-10Marcellin, P. vd. (2009) "A finite course of peginterferon alfa-2a results in inactive chronic hepatitis b and hbsag clearance 5 years post-treatment in patients with hbeag-negative disease: Baseline characteristics and predictive factors of long-term response". Hepatology, 50(4), 487A-487A.0270-9139http://hdl.handle.net/11452/26985Bu çalışma, 30 Ekim - 03 Kasım 2009 tarihleri arasında Montreal[Kanada]’da düzenlenen 60. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyA finite course of peginterferon alfa-2a results in inactive chronic hepatitis b and hbsag clearance 5 years post-treatment in patients with hbeag-negative disease: Baseline characteristics and predictive factors of long-term responseMeeting Abstract000270456000388487A487A504Gastroenterology & hepatology